Enzymatic Synthesis Of Therapeutic Nucleosides Using A Highly Versatile Purine Nucleoside 2’-Deoxyribosyltransferase From Trypanosoma Brucei

The use of enzymes for the synthesis of nucleoside analogues offers several advantages over multistep chemical methods, including chemo-, regio- and stereoselectivity as well as milder reaction conditions. Herein, the production, characterization and utilization of a purine nucleoside 2’-deoxyribosy...

Full description

Autores:
Pérez, Elena
Sánchez Murcia, Pedro Alejandro
Jordaan, Justin
Blanco, María Dolores
Mancheño, José Miguel
Gago, Federico
Fernandez Lucas, Jesus
Tipo de recurso:
Article of journal
Fecha de publicación:
2018
Institución:
Corporación Universidad de la Costa
Repositorio:
REDICUC - Repositorio CUC
Idioma:
spa
OAI Identifier:
oai:repositorio.cuc.edu.co:11323/1015
Acceso en línea:
http://hdl.handle.net/11323/1015
https//doi.org/10.1002/cctc.201800775
https://repositorio.cuc.edu.co/
Palabra clave:
2‘-Deoxy-Ribosyltransferase
Biocatalysis
Enzyme Immobilization
Molecular Dynamics
Nucleoside Analogues
Rights
openAccess
License
Atribución – No comercial – Compartir igual
id RCUC2_624961f8985e4597d74d2f011ab64a4f
oai_identifier_str oai:repositorio.cuc.edu.co:11323/1015
network_acronym_str RCUC2
network_name_str REDICUC - Repositorio CUC
repository_id_str
dc.title.eng.fl_str_mv Enzymatic Synthesis Of Therapeutic Nucleosides Using A Highly Versatile Purine Nucleoside 2’-Deoxyribosyltransferase From Trypanosoma Brucei
title Enzymatic Synthesis Of Therapeutic Nucleosides Using A Highly Versatile Purine Nucleoside 2’-Deoxyribosyltransferase From Trypanosoma Brucei
spellingShingle Enzymatic Synthesis Of Therapeutic Nucleosides Using A Highly Versatile Purine Nucleoside 2’-Deoxyribosyltransferase From Trypanosoma Brucei
2‘-Deoxy-Ribosyltransferase
Biocatalysis
Enzyme Immobilization
Molecular Dynamics
Nucleoside Analogues
title_short Enzymatic Synthesis Of Therapeutic Nucleosides Using A Highly Versatile Purine Nucleoside 2’-Deoxyribosyltransferase From Trypanosoma Brucei
title_full Enzymatic Synthesis Of Therapeutic Nucleosides Using A Highly Versatile Purine Nucleoside 2’-Deoxyribosyltransferase From Trypanosoma Brucei
title_fullStr Enzymatic Synthesis Of Therapeutic Nucleosides Using A Highly Versatile Purine Nucleoside 2’-Deoxyribosyltransferase From Trypanosoma Brucei
title_full_unstemmed Enzymatic Synthesis Of Therapeutic Nucleosides Using A Highly Versatile Purine Nucleoside 2’-Deoxyribosyltransferase From Trypanosoma Brucei
title_sort Enzymatic Synthesis Of Therapeutic Nucleosides Using A Highly Versatile Purine Nucleoside 2’-Deoxyribosyltransferase From Trypanosoma Brucei
dc.creator.fl_str_mv Pérez, Elena
Sánchez Murcia, Pedro Alejandro
Jordaan, Justin
Blanco, María Dolores
Mancheño, José Miguel
Gago, Federico
Fernandez Lucas, Jesus
dc.contributor.author.spa.fl_str_mv Pérez, Elena
Sánchez Murcia, Pedro Alejandro
Jordaan, Justin
Blanco, María Dolores
Mancheño, José Miguel
Gago, Federico
Fernandez Lucas, Jesus
dc.subject.eng.fl_str_mv 2‘-Deoxy-Ribosyltransferase
Biocatalysis
Enzyme Immobilization
Molecular Dynamics
Nucleoside Analogues
topic 2‘-Deoxy-Ribosyltransferase
Biocatalysis
Enzyme Immobilization
Molecular Dynamics
Nucleoside Analogues
description The use of enzymes for the synthesis of nucleoside analogues offers several advantages over multistep chemical methods, including chemo-, regio- and stereoselectivity as well as milder reaction conditions. Herein, the production, characterization and utilization of a purine nucleoside 2’-deoxyribosyltransferase (PDT) from Trypanosoma brucei are reported. TbPDT is a dimer which displays not only excellent activity and stability over a broad range of temperatures (50–70 °C), pH (4–7) and ionic strength (0–500 mM NaCl) but also an unusual high stability under alkaline conditions (pH 8–10). TbPDT is shown to be proficient in the biosynthesis of numerous therapeutic nucleosides, including didanosine, vidarabine, cladribine, fludarabine and nelarabine. The structure-guided replacement of Val11 with either Ala or Ser resulted in variants with 2.8-fold greater activity. TbPDT was also covalently immobilized on glutaraldehyde-activated magnetic microspheres. MTbPDT3 was selected as the best derivative (4200 IU/g, activity recovery of 22 %), and could be easily recaptured and recycled for >25 reactions with negligible loss of activity. Finally, MTbPDT3 was successfully employed in the expedient synthesis of several nucleoside analogues. Taken together, our results support the notion that TbPDT has good potential as an industrial biocatalyst for the synthesis of a wide range of therapeutic nucleosides through an efficient and environmentally friendly methodology.
publishDate 2018
dc.date.accessioned.none.fl_str_mv 2018-11-14T21:53:34Z
dc.date.available.none.fl_str_mv 2018-11-14T21:53:34Z
dc.date.issued.none.fl_str_mv 2018-07-18
dc.type.spa.fl_str_mv Artículo de revista
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/ART
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/acceptedVersion
format http://purl.org/coar/resource_type/c_6501
status_str acceptedVersion
dc.identifier.issn.spa.fl_str_mv 18673880
dc.identifier.uri.spa.fl_str_mv http://hdl.handle.net/11323/1015
dc.identifier.doi.spa.fl_str_mv https//doi.org/10.1002/cctc.201800775
dc.identifier.instname.spa.fl_str_mv Corporación Universidad de la Costa
dc.identifier.reponame.spa.fl_str_mv REDICUC - Repositorio CUC
dc.identifier.repourl.spa.fl_str_mv https://repositorio.cuc.edu.co/
identifier_str_mv 18673880
Corporación Universidad de la Costa
REDICUC - Repositorio CUC
url http://hdl.handle.net/11323/1015
https//doi.org/10.1002/cctc.201800775
https://repositorio.cuc.edu.co/
dc.language.iso.none.fl_str_mv spa
language spa
dc.rights.spa.fl_str_mv Atribución – No comercial – Compartir igual
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Atribución – No comercial – Compartir igual
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.publisher.spa.fl_str_mv ChemCatChem
institution Corporación Universidad de la Costa
bitstream.url.fl_str_mv https://repositorio.cuc.edu.co/bitstream/11323/1015/1/Enzymatic%20Synthesis%20Of%20Therapeutic%20Nucleosides.pdf
https://repositorio.cuc.edu.co/bitstream/11323/1015/2/license.txt
https://repositorio.cuc.edu.co/bitstream/11323/1015/4/Enzymatic%20Synthesis%20Of%20Therapeutic%20Nucleosides.pdf.jpg
https://repositorio.cuc.edu.co/bitstream/11323/1015/5/Enzymatic%20Synthesis%20Of%20Therapeutic%20Nucleosides.pdf.txt
bitstream.checksum.fl_str_mv d241c17576da95c4a53bc69446c751c6
8a4605be74aa9ea9d79846c1fba20a33
003783e65d6faba15676be6aa174786c
990e3f7782ef2fb6a6a13dcb0734dd9d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Universidad de La Costa
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1808400264352235520
spelling Pérez, Elena8a6d9e8a685afeebaaf8fb8c1f2b627aSánchez Murcia, Pedro Alejandro193226d9c95f451aa3df0e255424f2c4Jordaan, Justin406cda6b514ffdd18ba17701827a23aeBlanco, María Doloresab65b615d929f3b92c470a3060253ac9300Mancheño, José Miguel481885411e814b00ff2618e9424c4e0dGago, Federicob18cc388aeefbee1b9c30a5534f66494Fernandez Lucas, Jesus8a93c53d89f531d9974dd13de076402b2018-11-14T21:53:34Z2018-11-14T21:53:34Z2018-07-1818673880http://hdl.handle.net/11323/1015https//doi.org/10.1002/cctc.201800775Corporación Universidad de la CostaREDICUC - Repositorio CUChttps://repositorio.cuc.edu.co/The use of enzymes for the synthesis of nucleoside analogues offers several advantages over multistep chemical methods, including chemo-, regio- and stereoselectivity as well as milder reaction conditions. Herein, the production, characterization and utilization of a purine nucleoside 2’-deoxyribosyltransferase (PDT) from Trypanosoma brucei are reported. TbPDT is a dimer which displays not only excellent activity and stability over a broad range of temperatures (50–70 °C), pH (4–7) and ionic strength (0–500 mM NaCl) but also an unusual high stability under alkaline conditions (pH 8–10). TbPDT is shown to be proficient in the biosynthesis of numerous therapeutic nucleosides, including didanosine, vidarabine, cladribine, fludarabine and nelarabine. The structure-guided replacement of Val11 with either Ala or Ser resulted in variants with 2.8-fold greater activity. TbPDT was also covalently immobilized on glutaraldehyde-activated magnetic microspheres. MTbPDT3 was selected as the best derivative (4200 IU/g, activity recovery of 22 %), and could be easily recaptured and recycled for >25 reactions with negligible loss of activity. Finally, MTbPDT3 was successfully employed in the expedient synthesis of several nucleoside analogues. Taken together, our results support the notion that TbPDT has good potential as an industrial biocatalyst for the synthesis of a wide range of therapeutic nucleosides through an efficient and environmentally friendly methodology.spaChemCatChemAtribución – No comercial – Compartir igualinfo:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf22‘-Deoxy-RibosyltransferaseBiocatalysisEnzyme ImmobilizationMolecular DynamicsNucleoside AnaloguesEnzymatic Synthesis Of Therapeutic Nucleosides Using A Highly Versatile Purine Nucleoside 2’-Deoxyribosyltransferase From Trypanosoma BruceiArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/acceptedVersionORIGINALEnzymatic Synthesis Of Therapeutic Nucleosides.pdfEnzymatic Synthesis Of Therapeutic Nucleosides.pdfapplication/pdf370210https://repositorio.cuc.edu.co/bitstream/11323/1015/1/Enzymatic%20Synthesis%20Of%20Therapeutic%20Nucleosides.pdfd241c17576da95c4a53bc69446c751c6MD51open accessLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.cuc.edu.co/bitstream/11323/1015/2/license.txt8a4605be74aa9ea9d79846c1fba20a33MD52open accessTHUMBNAILEnzymatic Synthesis Of Therapeutic Nucleosides.pdf.jpgEnzymatic Synthesis Of Therapeutic Nucleosides.pdf.jpgimage/jpeg50239https://repositorio.cuc.edu.co/bitstream/11323/1015/4/Enzymatic%20Synthesis%20Of%20Therapeutic%20Nucleosides.pdf.jpg003783e65d6faba15676be6aa174786cMD54open accessTEXTEnzymatic Synthesis Of Therapeutic Nucleosides.pdf.txtEnzymatic Synthesis Of Therapeutic Nucleosides.pdf.txttext/plain1956https://repositorio.cuc.edu.co/bitstream/11323/1015/5/Enzymatic%20Synthesis%20Of%20Therapeutic%20Nucleosides.pdf.txt990e3f7782ef2fb6a6a13dcb0734dd9dMD55open access11323/1015oai:repositorio.cuc.edu.co:11323/10152023-12-14 17:47:30.538open accessRepositorio Universidad de La Costabdigital@metabiblioteca.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